HY-100128-10mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-100mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-25mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-5mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100128-50mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
HY-100423-1mg
|
MedChemexpress LLC
|
Eltanexor [CAS 1642300-52-4]
|
|
Cancer-programmed cell death
|
|
HY-100423-10mg
|
MedChemexpress LLC
|
Eltanexor [CAS 1642300-52-4]
|
|
Cancer-programmed cell death
|
|
HY-100423-100mg
|
MedChemexpress LLC
|
Eltanexor [CAS 1642300-52-4]
|
|
Cancer-programmed cell death
|
|
HY-100423-5mg
|
MedChemexpress LLC
|
Eltanexor [CAS 1642300-52-4]
|
|
Cancer-programmed cell death
|
|
HY-100423-50mg
|
MedChemexpress LLC
|
Eltanexor [CAS 1642300-52-4]
|
|
Cancer-programmed cell death
|
|
HY-100832-10mg
|
MedChemexpress LLC
|
UNC3866 [CAS 1872382-47-2]
|
|
Cancer-programmed cell death
|
|
HY-100832-100mg
|
MedChemexpress LLC
|
UNC3866 [CAS 1872382-47-2]
|
|
Cancer-programmed cell death
|
|
HY-100832-25mg
|
MedChemexpress LLC
|
UNC3866 [CAS 1872382-47-2]
|
|
Cancer-programmed cell death
|
|
HY-100832-5mg
|
MedChemexpress LLC
|
UNC3866 [CAS 1872382-47-2]
|
|
Cancer-programmed cell death
|
|
HY-100832-50mg
|
MedChemexpress LLC
|
UNC3866 [CAS 1872382-47-2]
|
|
Cancer-programmed cell death
|
|
HY-101093-1mg
|
MedChemexpress LLC
|
CA-170 [CAS 1673534-76-3]
|
|
COVID-19-immunoregulation
|
|
HY-101093-10mg
|
MedChemexpress LLC
|
CA-170 [CAS 1673534-76-3]
|
|
COVID-19-immunoregulation
|
|
HY-101093-100mg
|
MedChemexpress LLC
|
CA-170 [CAS 1673534-76-3]
|
|
COVID-19-immunoregulation
|
|
HY-101093-25mg
|
MedChemexpress LLC
|
CA-170 [CAS 1673534-76-3]
|
|
COVID-19-immunoregulation
|
|
HY-101093-5mg
|
MedChemexpress LLC
|
CA-170 [CAS 1673534-76-3]
|
|
COVID-19-immunoregulation
|
|
HY-101093-50mg
|
MedChemexpress LLC
|
CA-170 [CAS 1673534-76-3]
|
|
COVID-19-immunoregulation
|
|
HY-10238-10mg
|
MedChemexpress LLC
|
Danoprevir [CAS 850876-88-9]
|
|
COVID-19-anti-virus
|
|
HY-10238-100mg
|
MedChemexpress LLC
|
Danoprevir [CAS 850876-88-9]
|
|
COVID-19-anti-virus
|
|
HY-10238-5mg
|
MedChemexpress LLC
|
Danoprevir [CAS 850876-88-9]
|
|
COVID-19-anti-virus
|
|
HY-10238-50mg
|
MedChemexpress LLC
|
Danoprevir [CAS 850876-88-9]
|
|
COVID-19-anti-virus
|
|